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Neurological disorders disrupt the equilibrium within the brain and spinal cord ecosystems. Ecology reuses,
recycles, and reduces to help maintain the balance across ecosystems. Likewise, neuroprosthetics can help
the brain help itself with ecoprosthetic designs that integrate the principles of the ‘‘three ‘R’s.’’Nervous System Habitats
The word ecology derives from the Greek
oikos, meaning habitat, and logos, sci-
ence. Thus, ecology is the science of
habitat. The CNS is a complex habitat
wherein multifaceted nervous structures
have been piled up during evolution.
Each of these neural elements occupies
dedicated niches that constantly interact
to maintain the finely tuned balance within
their ecosystem: the brain and spinal
cord.
Natural ecosystems combine multiple
habitats arranged in horizontal and verti-
cal stratifications that are both autono-
mous and interdependent. Similarly, the
CNS is an assembly of modular subsys-
tems that combine high-density local
circuits and long-range connectivity.
Local circuit organization enables a high
degree of automaticity (Grillner, 2006).
For example, the functional modules of
the spinal cord are able to produce
complex locomotor behavior without
the need for brain input (Grillner, 2006;
van den Brand et al., 2012). In fact, most
of our daily movements escape our
conscious attention. In turn, long-range
connections and distributed connector
hubs enable seamless communication
between the subsystems, which is critical
to maintain harmony across the habitats.
Thus, our nervous systems seek both
automaticity and interdependence to
minimize the overall energy expenditure
while allowing production of refinedmotor
and cognitive behaviors. This apparent
simplicity dissimulates highly complex in-
teractions to maintain equilibrium within
and between the ecosystems (Figure 1A).Emergence of natural disasters or
deprivation of resources leads to a sud-
den or progressive imbalance in the eco-
systems that endangers living organisms
throughout the stratifications. Similarly,
acute or chronic dysfunction in one seem-
ingly insignificant circuit or processing
loop of our nervous systems can, and
often does, lead to dramatic conse-
quences that induce transient or perma-
nent deficits in cognitive ability and motor
control (Borton et al., 2013).
Our ecological footprint and its threat-
ening impact on biodiversity, natural
resources, and human health triggered
environmental strategies to preserve our
ecosystems. This awareness is changing
the lifestyles in occidental countries,
which have anchored the ‘‘three ‘R’s’’
principles in the regulation of individual
and collective behaviors (Figure 1B).
The field of neuroprosthetics has too
reached an age of maturity, when similar
questions need to be addressed and
ecological strategies defined and imple-
mented to ensure the sustainability of
ongoing and contemplated therapeutic
developments.
Ecoprostheses
Neuroprosthetics emergednearly 40 years
ago. The discovery of key physiological
principles underlying brain functions
and advances in electronic and computer
industries supported the invention of
engineered systems that are chronically
implanted in the body to treat neurological
disorders. These neuroprosthetic treat-
ments tap into spared elements of
the nervous system to replace or restoreNeurlost or impaired neurological functions.
Neuroprosthetic treatments conceived
in the past century have translated into
common medical practices that have
improved the livesof countless individuals.
Cochlear implants restore hearing in deaf
people, deep-brain stimulation alleviates
Parkinsonian symptoms, and spinal
cord neuromodulation attenuates chronic
neuropathic pain (Borton et al., 2013).
These successes triggered a massive
infatuation of scientists, engineers, clini-
cians, politicians, and the general public
for neuroprosthetics, which unleashed
substantial funding opportunities. This
virtuous conjecture encouraged the frantic
development of myriad neurotechnolo-
gies, leading to a exponential increase
in the number of scientific publications
that contrasts with the anecdotal number
of new clinical applications (Wolpaw and
Winter Wolpaw, 2012). Admittedly, recent
neuroprosthetic demonstrators enticed
our imagination with realizations that a
few years agowere in the realm of science
fiction. For example, paralyzed people
have been able to operate multi-articu-
lated prosthetic arms to execute activities
of daily living using brain activity only
(Collinger et al., 2013; Hochberg et al.,
2012). However, these breakthroughs
remain confined to the sophisticated
environment of research laboratories,
where highly skilled engineers continu-
ously tune onerous, delicate, unaesthetic,
and unpractical technologies.
How to explain the discrepancy be-
tween the acceleration of technological
progress and the lack of concrete
clinical dissemination? We argue that theon 86, April 8, 2015 ª2015 Elsevier Inc. 29
Figure 1. Ecoprosthetic Design
(A) The nervous system is organized in finely interacting ecosystems
combining high-density local circuits and long-distance connections, similar
to the horizontal and vertical stratifications of natural habitats, such as forests.
(B) Application of the three ‘‘R’’s ecological principles to neuroprosthetic
designs.
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neuroprosthetic designs con-
tributes to hindering the
translation of new methods
and devices toward patient
benefit. In turn, an effective
strategy to catalyze develop-
ments toward useful medical
practices is to respect the
principles of ecology. We first
propose an analogy between
the ecological concept of the
three ‘‘R’’s—reuse, recycle,
and reduce—and neuropros-
thetics. We then discuss the
necessity to merge these
concepts in patient-centered
ecoprosthetic designs that
reach clinical fruition at the
fastest possible pace.
Reuse
CNSdisorders typically spare
the vast majority of nerve
fibers and neurons in thebrain and spinal cord. However, the loss
of neurons, circuits, and/or connections
disrupts the functionality of spared neural
elements and leads to multifaceted adap-
tations of their properties. For example, a
spinal cord injury physically disconnects
the brain from some or all of the neuronal
circuits in the spinal cord. Functional and
anatomical cartographies of cortical terri-
tories projecting to denervated regions
documented pronounced reorganization
of these neuronal networks. These adap-
tive changes, termed homeostatic plas-
ticity, contribute to reestablishing the bal-
ance within brain ecosystems (Davis,
2013). Likewise, a dramatic remodeling
of neurons, fibers, and synapses takes
place within denervated spinal segments,
below injury. However, these responses
are maladaptive and often lead to
neuronal dysfunction, spasticity, and
chronic pain—an ensemble of neuropa-
thologies that significantly impact the
quality of life for spinal cord-injured
individuals.
Neuroprosthetics has deployed two
strategies to reuse spared neuronal ele-
ments, broadly divided into replacement
and restoration strategies (Borton et al.,
2013). Replacement primarily refers
to the field of brain-machine interface.
These interventions exploit sensing neural
interfaces that are plugged into spared30 Neuron 86, April 8, 2015 ª2015 Elsevier Inbrain regions to read neuronal activity.
Translation algorithms map features de-
coded from brain signals to intended
prosthetic actions. Brain-machine inter-
faces have enabled healthy and paralyzed
people to control sophisticated devices
including computers, robots, and pros-
thetic arms (Collinger et al., 2013; Hoch-
berg et al., 2012).
Restoration refers to neuromodulation
therapies. These interventions exploit
pharmacological, electrical, and optical
neuromodulation paradigms to write into
the brain and spinal cord in order to regu-
late dysfunctional circuits or reawaken
dormant neuronal networks. For example,
dopamine precursors and deep-brain
stimulation of the basal ganglia circuitry
have become common therapies to
alleviate cognitive and motor symptoms
associated with Parkinson’s disease.
Electrochemical neuromodulation has
also shown the ability to transform spinal
locomotor circuits from dormant to
highly functional states after injury. The
combination of amonoamine replacement
therapy and electrical stimulation applied
over the dorsal aspect of lumbar segments
restored full weight-bearing locomotion
in rats with complete spinal cord injury
(van den Brand et al., 2012). Electrical
neuromodulation of lumbar segments
also improved standing and restoredc.supraspinal control of move-
ments inparaplegic individuals
(Angeli et al., 2014). Themech-
anisms through which neuro-
modulation therapies mediate
functional benefits remain
elusive. The underlying physi-
ological principles are likely
distinct for each neurological
disorder, neuromodulation
modality, andanatomical loca-
tion (Lozano and Lipsman,
2013). However, neuromo-
dulation therapies all have in
common that they mediate
immediate effects through
their direct or indirect influ-
ences on anatomically intact
butdysfunctional neuronal ele-
ments—these therapies reuse
spared circuits.
Augmented Reuse
Various replacement and
restoration strategies reusespared neural elements that have lost
their output communication channels or
have become isolated from the rest
of the habitat. Nevertheless, the amount
of reused circuits and connections
represents a fraction of the vast reservoir
of preserved brain and spinal cord
regions. For example, even the most
sophisticated brain-machine interfaces
leveraged fewer than 300 neurons
located in a small patch of cortex
to interpret the individual’s intended
motor action. Neurotechnology capable
of stimulating and recording large-scale
brain activity wirelessly is becoming
available for basic research and clinical
applications (Yin et al., 2014). Therefore,
a network of bidirectional neural implants
covering functionally distinct brain re-
gions is likely to equip brain-machine in-
terfaces with more natural, sensorized,
stable, and expanded control capacities.
This ecological approach requires a
more profound knowledge of neural
processes underlying cognition, motor
planning, and execution. To this end,
the Human Brain Project (https://www.
humanbrainproject.eu/) and the BRAIN
Initiative from the National Institutes
of Health (http://www.braininitiative.nih.
gov/index.htm) may well expand the
range of available options to reuse cir-
cuits in ecoprosthetic designs.
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modulation therapies. For example, elec-
trical neuromodulation of the spinal cord
has mediated significant improvement of
locomotor functions in animal models
(van den Brand et al., 2012) and humans
(Angeli et al., 2014) with spinal cord injury.
However, existing neuromodulation
therapies deliver stimulation to restricted
spinal cord locations and remain constant
throughout gait execution, regardless
of the subject’s intention or the current
locomotor state. Walking requires the
activation of spatially distributed spinal
motor circuits following precise temporal
sequences (Grillner, 2006). Accordingly,
spinal neuromodulation therapies deliv-
ering stimulation at the correct location
and with the correct timing to reproduce
the natural dynamics of spinal motor
circuit activation are likely to mediate
superior facilitation of locomotion after
neurological disorders. This approach is
ecological, as the goal is to reuse the
largest possible amount of spared circuits
while minimizing the overall amount
of injected energy at any given time.
The same principles apply to a wide spec-
trum of neuromodulation therapies. This
awareness has motivated the ElectRx
program of the Defense Advanced
Research Projects Agency (http://www.
darpa.mil/newsevents/releases/2014/08/
26.aspx). This program, which is part
of the BRAIN Initiative portfolio, aims
to develop intelligent pacemakers that
personalize neuromodulation therapies
through closed-loop control of stimulation
parameters.
Recycling
Neuroprosthetics integrate the concept
of recycling along two timescales. The
first strategy, which produces immediate
therapeutic effects, consists of recycling
energy within neuronal circuits. The sec-
ond, long-term strategy seeks to recycle
spared circuits and connections into
de novo elements to prevent waste of
potentially useful neuronal material.
Excessive use of natural resources by
a restricted group of individuals can
exhaust habitats. In Galapagos, the glut-
tony of marine iguanas has depleted
commercial fish, destroyed marine envi-
ronments, and crippled the local com-
munity. Similarly, schizophrenia or obses-
sive-compulsive disorders are in part dueto excessive activity in restricted brain re-
gions or specific processing loops. While
disparate in their etiologies, these neuro-
logical conditions share comparable
disorders of circuit function, also termed
circuitopathies (Lozano and Lipsman,
2013). In consequence, neuroprosthetics
responded with a common methodology:
the delivery of energy into pathogenic
circuits to dissimulate abnormal activity
or scramble error messages. This surgical
approach, primarily based on deep-brain
stimulation, aims to recycle energy
throughout unbalanced ecosystems in
order to recalibrate circuit dynamics.
According to https://www.clinicaltrials.
gov/, there are nearly 100 ongoing clinical
trials that are exploring the impact of
deep-brain stimulation for alleviating
detrimental effects of many neurological
disorders, including major depression
disorder, obsessive-compulsive disorder,
chronic pain, and dystonia.
Natural catastrophes can devastate
lands and dwindle resources. For
example, a forest fire can extinguish the
majority of habitats across a broad land-
scape. However, these catastrophic
events also offer the opportunity to
recycle spared elements in order to
rebuild ecosystems. Likewise, traumatic
injuries, cerebral infarction, and other
sudden neural damage open a window
of opportunity for enhanced neuroplastic-
ity, which can mediate extensive restora-
tion of functions after moderate insults.
Currently, neurorehabilitation is the only
common medical practice to harness
the potential for neuroplasticity after
neurological disorders. However, neuro-
prosthetic interventions can boost
activity-dependent neuroplasticity when
delivered during training. For example,
robot-assisted gait rehabilitation enabled
by electrochemical neuromodulation of
spinal circuits promoted extensive and
ubiquitous remodeling of spared neuronal
connections after severe spinal cord
injury. This neuroprosthetic rehabilitation
reestablished supraspinal control over
refined locomotor movements in other-
wise paralyzed rats (van den Brand
et al., 2012). Neuroprosthetic systems
have also been integrated in the rehabili-
tation of upper limb functions after spinal
cord injury or stroke (Dimyan and Cohen,
2011). In all these applications, the
neuroprostheses introduce energy intoNeurthe brain, spinal cord, or muscles to
increase activity and thus augment
neuroplasticity. The resulting circuits and
connections differ from those of the
original ecosystem—they are recycled—
but they effectively improve functionality
throughout the habitats.
Augmented Recycling
Delivery of energy into CNS structures
alleviates pain and ameliorates cognitive
and motor deficits after various neuro-
logical disorders. However, current ap-
proaches remain empirical. Neurologists
tune the locations and parameters of
stimulation based on visual observations.
After titration, the patient has no or very
limited control over stimulation features.
The amount of injected energy is not
adapted to the current state of pathogenic
circuits or to the intended behavior. This
brute-force approach not only results in
a waste of energy, but also fails to exploit
the full therapeutic potential of these inter-
ventions. Instead, automated closed-loop
control systems based on detection of
pathological neural activity yield great
potential to optimally titrate therapies to
meet dynamic, patient-specific needs
(Rosin et al., 2011). Brain-machine inter-
face technology offers the opportunity
to incorporate brain signals into closed-
loop stimulation algorithms. The user re-
gains a direct access to the onset and
adjustment of neuromodulation therapies.
Preliminary experiments suggest that
electrical stimulation protocols guided
by online extraction of motor intention
enhance neuroplasticity and recovery
after stroke (Biasiucci et al., 2013). The
industry has developed chronically
implantable, closed-loop neuromodula-
tion platforms with concurrent sensing
and stimulation capacities to support the
design of such ecoprostheses (Stanslaski
et al., 2012). This ecological strategy
is equivalent to smart grid technology
platforms that automatically gather infor-
mation about behaviors of suppliers and
consumers to improve the efficacy and
reliability of the production and distri-
bution of electricity.
Reduce, Reduce, Reduce
The proliferation of bulky exoskeletons,
phantasmagoric cyborgs, and ‘‘brain-to-
X’’ interfaces are vivid examples of the
waste of resources in neuroprosthetics.on 86, April 8, 2015 ª2015 Elsevier Inc. 31
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essential avenues to continue, a more
immediate clinical impact may arise from
reduction and refinement of current
treatments.
Neural engineers have developed a
flurry of non-invasive rehabilitation tech-
nologies including robots, stimulation
paradigms, and brain-machine interfaces
based on electroencephalographic sig-
nals. These neuroprostheses have
enabled disabled people to control
devices and to mobilize their muscles.
Despite the potential of these neuropros-
theses to enhance rehabilitation out-
comes, they have yet to incorporate the
toolbox of professional therapists. Like-
wise, electrical vehicles have become
mature technologies that could compete
with non-ecological transportations, but
the lack of recharging infrastructures is
preventing their adoption by consumers.
Novel translational incentives are thus
necessary to standardize neurotechnolo-
gies, educate care providers, and build
consortiums capable of personalizing
neuroprosthetic treatments at the
bedside (Borton et al., 2013). While safety
and monetary considerations remain the
chief concerns in our modern societies,
it is imperative that discoveries and
technological developments populating
the field of neuroprosthetics are delivered
to patients at the fastest pace possible.
Deep-brain stimulation relies on dated
technologies developed in the 1980s.
The past two decades have brought
major advances in electronic, computer,
energy, and communication industries,
which offer an arsenal of technologies
to improve the efficacy and comfort of
this treatment. These ameliorations
include reduction of implant size, en-
hanced lead features, increased battery
life, infrastructure to recharge batteries
at hospitals and homes, closed-loop
control of titration, improved stimulation
algorithms, expanded external communi-
cation range, user-friendly communica-
tion interfaces, etc. These incremental
improvements may contribute to increas-
ing patient acceptance of implantable
devices, intensifying the dissemination of
these treatments. However, these devel-
opments require massive investments to
establish the technologies and pass the
regulatory hoops, which have refrained
industries from refining their devices at a32 Neuron 86, April 8, 2015 ª2015 Elsevier Infast pace. Policy-makers responded to
the reticence of industry to follow ecolog-
ical principles with incentive measures.
Funding agencies and academic circles
promote the contrary. The culture and
philosophy of decision-making basic
scientists encourage the selection of
disruptive ideas and innovations against
pragmatism. Despite the grand goal of
helping patients, research-funding com-
mittees reluctantly support incremental
science or validation of technologies in a
clinical scenario.
This oxymoron applies to the flourishing
field of brain-machine interface. Basic
discoveries and technology-driven break-
throughs have escalated. Highly publi-
cized publications in high-impact-factor
journals have rewarded the involved sci-
entists, fostering academic careers in
rapidly expanding neural engineering
departments. However, the translation of
these technologies into tangible patient
benefits will require more than pairing an
academic laboratory with a medical
team. Academic systems will not reward
translational neuroprosthetic scientists
who are constrained to operate in large
multidisciplinary teams that dissimulate
individual contributions. Whose responsi-
bility is it, then, to shepherd translation-
oriented bench discoveries toward the
bedside?We believe that this responsibil-
ity is incumbent upon neuroscientists
in academy and hospitals who have
discovered basic principles with transla-
tional potentials. These scientists have
the more profound knowledge on the
pros and cons of their findings. They
have at heart to continue basic research
to decipher the therapeutic mechanisms,
which is essential for efficient translation
from bench to bedside (Duda et al., 2014).
Involvement of basic scientists in
translation requires the implementation
of ecological principles throughout the
bench to bedside, starting with the orga-
nization of universities. The academic
system is educating countless engineers,
doctors, and postdoctoral fellows who
have only a few years to demonstrate
their scientific and intellectual capacities.
The brightest minds achieve basic dis-
coveries or fabricate cutting-edge tech-
nologies, but then leave them behind in
a no man’s land. Reduction of seasoned
investigator cohorts for the perennial
stabilization of mature translational scien-c.tists is essential to bridge the ten-year gap
separating basic discoveries and early-
stage neurotechnologies to neuropros-
thetic treatments (Alberts et al., 2014).
This reduction implies a change in the
academic culture. Reward systems must
focus not only on the number and quality
of publications, but also value the trans-
lational impact of neuroscientists, their
patent portfolio, and even their ability to
commercialize medical devices (Sanberg
et al., 2014). This unconventional distribu-
tion of human resources necessitates
dedicated translational hubs and novel
funding mechanisms. These research in-
frastructures must gather neuroscientists,
neurologists, neurosurgeons, and neuro-
engineers who partner with leading indus-
tries, medical device experts, patent
specialists, and regulatory bodies (Duda
et al., 2014). A few initiatives are emerging
to support such translational efforts. For
example, the Swiss entrepreneur and
philanthropist Hansjo¨rg Wyss donated
unprecedented single endowments to
establish translational biomedical centers
in Boston, Geneva, and Zurich. These
centers provide high-end research infra-
structures, skilled human resources,
and industrial connections to accommo-
date selected translation-oriented basic
research projects. The mission of these
centers is to bridge the difficult in-be-
tween step separating basic discoveries
from viable neurobusiness.
Merging the Three ‘‘R’’s to Reach
Clinical Fruition
We sought to establish parallels between
ecological principles and neuroprosthetic
designs. We proposed illustrative exam-
ples to reuse circuits, recycle energy,
and reduce technology for the develop-
ment of useful patient-centered ecopros-
theses. These provocative analogies are
the biased views of a basic neuroscientist
lost in translation and a functional neu-
rosurgeon frustrated by translational
roadblocks who have joined forces to
fertilize neuroprosthetic platforms in the
Swiss health valley. Our reflections and
struggles led us to believe that the
systematic integration of the three ‘‘R’’s
principles in neuroprosthetic treatment
designs and decision-making policies
may help to accelerate clinical fruition.
But challenges lie ahead. Without a
drastic change in scientist mindsets,
Neuron
NeuroViewacademic reward system, research
infrastructures, stakeholders’ mentalities,
and funding mechanisms, the sum
of accumulated neurotechnologies and
knowledge will not result in concrete
patient benefits.ACKNOWLEDGMENTS
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